Fig. 6From: Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistanceSummary of therapeutic strategies for osimertinib resistance. Therapeutic strategies are comprised of targeted therapy, chemotherapy and immunotherapy; in addition, combination regimens will be considered depending on the individual characteristics of patientsBack to article page